If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven Renovar Regulatory News (MRV)

Share Price Information for Maven Renovar (MRV)

Share Price is delayed by 15 minutes
Get Live Data
53.00    0.00 (0.00%)
Bid:
52.50
Ask:
53.50
Spread: 1.00 (1.905%)
Market Cap: £67.96m
MRV Live PriceLast checked at - London Stock Exchange

Intraday Maven Renovar Share Chart

Rule 8.3- Murray VCT 2

1 Dec 2005 15:08

Brewin Dolphin Securities Ld01 December 2005 FORM 8.3 DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MORE (Rule 8.3 of the City Code on Takeovers and Mergers) 1. KEY INFORMATION Name of person dealing (Note 1) BREWIN DOLPHIN SECURITIES Company dealt in MURRAY VCT 2 Class of relevant security ORD GBP0.10to which the dealings being disclosed relate (Note 2) Date of dealing 30/11/05 2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE (a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3) Long Short Number (%) Number (%) (1) Relevant securities 548,262 1.5445%(2) Derivatives (other than options) (3) Options and agreements to purchase/sell Total 548,262 1.5445% (b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3) Class of relevant security: Long Short Number (%) Number (%) (1) Relevant securities (2) Derivatives (other than options) (3) Options and agreements to purchase/sell Total (c) Rights to subscribe (Note 3) Class of relevant security: Details 3. DEALINGS (Note 4) (a) Purchases and sales Purchase/sale Number of securities Price per unit (Note 5) PURCHASE 12,500 31.00p (b) Derivatives transactions (other than options) Product name, Long/short Number of securities Price per unit e.g. CFD (Note 6) (Note 7) (Note 5) (c) Options transactions in respect of existing securities(i) Writing, selling, purchasing or varying Product Writing, Number of Exercise Type, e.g. Expiry Option moneyname, selling, securities price American, date paid/e.g. purchasing, to which European received call varying etc. the option etc. per unit option relates (Note 5) (Note 7) (ii) Exercising Product name, e.g. Number of securities Exercise price per unit call option (Note 5) (d) Other dealings (including new securities)(Note 4) Nature of transaction Details Price per unit (Note 8) (if applicable) (Note 5) 4. OTHER INFORMATION Agreements, arrangements or understandings relating to options or derivatives Full details of any agreement, arrangement or understanding between the persondisclosing and any other person relating to the voting rights of any relevantsecurities under any option referred to on this form or relating to the votingrights or future acquisition or disposal of any relevant securities to which anyderivative referred to on this form is referenced. If none, this should bestated. Is a Supplemental Form 8 attached? (Note 9) YES/NO Date of disclosure 01/12/05 Contact name LEE JEMMERSON Telephone number 0191 279 7334 If a connected EFM, name of offeree/offeror with which connected If a connected EFM, state nature of connection (Note 10) Notes The Notes on Form 8.3 can be viewed on the Takeover Panel's website atwww.thetakeoverpanel.org.uk This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
13th Feb 20263:08 pmRNSUnaudited Net Asset Value
10th Feb 202612:15 pmRNSTransaction in Own Shares
10th Feb 202612:12 pmRNSStatement re Provision 5.2.4 of the AIC Code
6th Feb 20264:42 pmRNSUnaudited Net Asset Value
3rd Feb 20262:42 pmRNSTransaction in Own Shares
3rd Feb 202611:41 amRNSUnaudited Net Asset Value
2nd Feb 20267:00 amRNSChange of Company Secretary and Registered Office
2nd Feb 20267:00 amRNSTotal Voting Rights
30th Jan 20262:36 pmRNSTransaction in Own Shares
27th Jan 202610:00 amRNSTransaction in Own Shares
23rd Jan 20264:29 pmRNSUnaudited Net Asset Value
20th Jan 20264:28 pmRNSTransaction in Own Shares
19th Jan 202610:03 amRNSUnaudited Net Asset Value
14th Jan 20262:16 pmRNSTransaction in Own Shares
13th Jan 202612:11 pmRNSDirector Declaration
9th Jan 20263:51 pmRNSUnaudited Net Asset Value
6th Jan 20265:02 pmRNSTransaction in Own Shares
2nd Jan 20262:16 pmRNSUnaudited Net Asset Value
2nd Jan 202612:26 pmRNSTotal Voting Rights
29th Dec 202511:59 amRNSTransaction in Own Shares
29th Dec 202511:59 amRNSTransaction in Own Shares
19th Dec 20253:39 pmRNSUnaudited Net Asset Value
18th Dec 202512:35 pmRNSTransaction in Own Shares
18th Dec 202512:35 pmRNSTransaction in Own Shares
12th Dec 20251:53 pmRNSUnaudited Net Asset Value
10th Dec 20254:00 pmRNSTransaction in Own Shares
5th Dec 20253:44 pmRNSUnaudited Net Asset Value
2nd Dec 20252:24 pmRNSUnaudited Net Asset Value
1st Dec 20253:54 pmRNSTransaction in Own Shares
1st Dec 20259:43 amRNSTotal Voting Rights
28th Nov 20254:31 pmRNSTransaction in Own Shares
21st Nov 20254:42 pmRNSTransaction in Own Shares
21st Nov 20254:32 pmRNSUnaudited Net Asset Value
18th Nov 20251:06 pmRNSReplacement Net Asset Value(s) and Factsheet
17th Nov 20254:40 pmRNSNet Asset Value(s) and Factsheet
17th Nov 20259:17 amRNSTransaction in Own Shares
10th Nov 202511:20 amRNSNet Asset Value(s)
4th Nov 202512:33 pmRNSNet Asset Value(s)
3rd Nov 202510:05 amRNSTotal Voting Rights
30th Oct 202510:33 amRNSTransaction in Own Shares
24th Oct 20252:45 pmRNSNet Asset Value(s)
22nd Oct 20253:57 pmRNSTransaction in Own Shares
20th Oct 20251:39 pmRNSNet Asset Value(s)
10th Oct 20254:26 pmRNSNet Asset Value(s)
9th Oct 20257:01 amRNSDividend Declaration
9th Oct 20257:00 amRNSHalf-year Report
1st Oct 20255:00 pmRNSNet Asset Value(s)
26th Sep 20252:02 pmRNSNet Asset Value(s)
22nd Sep 202510:54 amRNSNet Asset Value(s)
12th Sep 20254:27 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.